- TWD35.93bn
- TWD36.62bn
- TWD25.08bn
- 69
- 28
- 69
- 58
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 23,791 | 25,422 | 32,525 | 29,130 | 25,079 |
Cost of Revenue | |||||
Gross Profit | 4,780 | 4,951 | 5,980 | 3,940 | 3,106 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 20,688 | 22,203 | 28,751 | 26,766 | 23,965 |
Operating Profit | 3,104 | 3,218 | 3,774 | 2,364 | 1,114 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 3,094 | 3,395 | 3,815 | 2,315 | 1,152 |
Provision for Income Taxes | |||||
Net Income After Taxes | 2,463 | 2,666 | 3,145 | 1,855 | 677 |
Net Income Before Extraordinary Items | |||||
Net Income | 2,463 | 2,666 | 3,145 | 1,855 | 677 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Dilution Adjustment | |||||
Diluted Net Income | 2,463 | 2,666 | 3,145 | 1,855 | 677 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 7.75 | 8.01 | 9.07 | 3.93 | 1.68 |
Dividends per Share |